511 related articles for article (PubMed ID: 33509878)
21. Extensive DVT and Pulmonary Embolism Leading to the Diagnosis of Coronavirus Disease 2019 in the Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.
Delcros Q; Rohmer J; Tcherakian C; Groh M
Chest; 2020 Dec; 158(6):e269-e271. PubMed ID: 33280767
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Embolism in Hospitalized Patient with Coronavirus Disease 2019 (COVID-19).
Rajabto W; Priantono D; Mulyadi R
Acta Med Indones; 2021 Oct; 53(4):493-496. PubMed ID: 35027499
[TBL] [Abstract][Full Text] [Related]
23. Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
Kosior DA; Undas A; Kopeć G; Hryniewiecki T; Torbicki A; Mularek-Kubzdela T; Windyga J; Pruszczyk P
Kardiol Pol; 2020 Jun; 78(6):642-646. PubMed ID: 32515570
[TBL] [Abstract][Full Text] [Related]
24. Catheter-directed thrombolysis to treat acute pulmonary thrombosis in a patient with COVID-19 pneumonia.
Pendower L; Benedetti G; Breen K; Karunanithy N
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32784245
[TBL] [Abstract][Full Text] [Related]
25. Saddle pulmonary embolism and thrombus-in-transit straddling the patent foramen ovale 28 days after COVID symptom onset.
Fujikura K; Fontes JD; Taub CC
Echocardiography; 2020 Aug; 37(8):1296-1299. PubMed ID: 32735050
[TBL] [Abstract][Full Text] [Related]
26. Lung perfusion assessed by SPECT/CT after a minimum of three months anticoagulation therapy in patients with SARS-CoV-2-associated acute pulmonary embolism: a retrospective observational study.
Berghaus TM; Bader S; Faul C; Haberl S; Schwarz F; Liebich A; Dierks A; Kircher M; Lapa C; Pfob CH
Respir Res; 2022 Oct; 23(1):296. PubMed ID: 36316693
[TBL] [Abstract][Full Text] [Related]
27. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
[TBL] [Abstract][Full Text] [Related]
28. A 61-Year-Old Man with Flank Pain.
Lee A
J Emerg Nurs; 2016 May; 42(3):253-4. PubMed ID: 27156604
[No Abstract] [Full Text] [Related]
29. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Volumetric Comparison of Direct Oral Anticoagulant and Vitamin K Antagonist Treatment for Pulmonary Thrombus Reduction During the Acute Phase in Symptomatic Patients.
Jujo K; Yoshida A; Fukushima K; Kikuchi Y; Minami Y; Murasaki K; Haruki S; Sekiguchi H; Tanaka H; Ogawa H; Hagiwara N
Am J Med Sci; 2020 Aug; 360(2):153-160. PubMed ID: 32563568
[TBL] [Abstract][Full Text] [Related]
31. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug.
D'Elia E; Gori M; Grosu A; Iorio A; Lorini FL; Falanga A; Di Marco F; Senni M
BMC Pulm Med; 2021 Mar; 21(1):102. PubMed ID: 33761886
[TBL] [Abstract][Full Text] [Related]
32. Thrombolytic Therapy for Pulmonary Embolism in COVID 19 ARDS: A Case Series.
Yelle S
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062801
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.
Ooi MWX; Rajai A; Patel R; Gerova N; Godhamgaonkar V; Liong SY
Eur J Radiol; 2020 Nov; 132():109336. PubMed ID: 33069986
[TBL] [Abstract][Full Text] [Related]
34. Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19.
Porres-Aguilar M; Tapson VF; Rivera-Lebron BN; Rali PM; Jiménez D; Porres-Muñoz M; Barraza S; Muñoz OC; Mukherjee D
J Investig Med; 2021 Aug; 69(6):1153-1155. PubMed ID: 34039677
[TBL] [Abstract][Full Text] [Related]
35. [Possibility of using coagulation factor Ⅱ and factor Ⅹ for warfarin monitoring in Chinese pulmonary embolism patients].
Yuan Y; Zhang T; Yan JW; Li JY; Fan JP; Shi JH; Chen Q
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(44):3456-3460. PubMed ID: 31826561
[No Abstract] [Full Text] [Related]
36. Venous thromboembolism and COVID-19: a case report and review of the literature.
Bhatt H; Singh S
J Med Case Rep; 2020 Oct; 14(1):188. PubMed ID: 33054805
[TBL] [Abstract][Full Text] [Related]
37. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
38. Acute cor pulmonale from saddle pulmonary embolism in a patient with previous COVID-19: should we prolong prophylactic anticoagulation?
Ali S; Mathew S; Pappachan JM
Int J Infect Dis; 2020 Aug; 97():299-302. PubMed ID: 32544670
[TBL] [Abstract][Full Text] [Related]
39. Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report.
Demir G; Hommos R; Al-Sirhan SS; Serhan HA; Haddadin M; Bin Rashid U; Chawa Y
J Med Case Rep; 2023 May; 17(1):223. PubMed ID: 37254113
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary embolism in acute medicine: a case-based review incorporating latest guidelines in the COVID-19 era.
Stevenson A; Davis S; Murch N
Br J Hosp Med (Lond); 2020 Jun; 81(6):1-12. PubMed ID: 32589531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
